TAK-102
TAK-102-1501
Phase 1 mab terminated
Quick answer
TAK-102 for Solid Tumors is a Phase 1 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated